CA
Continuum Advisory’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,268
| Closed | -$199K | – | 550 |
|
|
2025
Q1 | $199K | Buy |
3,268
+1,535
| +89% | +$93.6K | 0.03% | 391 |
|
|
2024
Q4 | $98K | Buy |
1,733
+227
| +15% | +$12.8K | 0.01% | 520 |
|
|
2024
Q3 | $88.1K | Buy |
1,506
+423
| +39% | +$24.7K | 0.01% | 550 |
|
|
2024
Q2 | $45K | Sell |
1,083
-61,656
| -98% | -$2.56M | 0.01% | 626 |
|
|
2024
Q1 | $2.81M | Buy |
+62,739
| New | +$2.81M | 0.42% | 51 |
|
|
2021
Q3 | – | Sell |
-4,099
| Closed | -$274K | – | 296 |
|
|
2021
Q2 | $274K | Buy |
+4,099
| New | +$274K | 0.09% | 221 |
|